Your session is about to expire
← Back to Search
Other
Blood Flow Restriction Training for Vascular Health
N/A
Waitlist Available
Led By Hirofumi Tanaka, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline measurement and measurement at 2 weeks
Awards & highlights
Study Summary
This trialinvestigates how different types of Blood Flow Restriction (BFR) resistance training affects vascular health, and if one type improves vascular health better than the other. Both types are equally effective at increasing muscle strength.
Who is the study for?
This trial is for healthy, sedentary or recreationally active young adults aged 18-40 who have agreed to participate. It's not suitable for those on cardiovascular medications, with morbid obesity, current smokers, people with hypertension or overt cardiovascular disease, anyone currently doing resistance training, or those diagnosed with COVID-19.Check my eligibility
What is being tested?
The study is examining how blood flow restriction (BFR) resistance training affects vascular function in participants. Two types of BFR devices are being compared: wide-rigid cuffs and narrow elastic bands. The hypothesis suggests that while both may increase muscle strength, the effects on vascular health could differ.See study design
What are the potential side effects?
Potential side effects might include minor and reversible impacts on vascular function from using wide-rigid cuffs for BFR training. Narrow elastic bands may improve vascular function but specific side effect profiles are not detailed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline measurement and measurement at 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline measurement and measurement at 2 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline grip strength at 2 weeks
Change from baseline muscle strength at 2 weeks
Change from baseline vascular function at 2 weeks
Secondary outcome measures
Blood flow responses to different types of cuff
Change from baseline arterial stiffness at 2 weeks
Change from baseline blood lactate concentration
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Wide-rigid cuffExperimental Treatment1 Intervention
The wide-rigid cuff will be randomly assigned to one of the subject's arms.
Group II: Narrow-elastic bandExperimental Treatment1 Intervention
The narrow-elastic band will be randomly assigned to another arm of the subject.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blood flow restriction resistance training
2020
N/A
~30
Find a Location
Who is running the clinical trial?
University of Texas at AustinLead Sponsor
356 Previous Clinical Trials
81,454 Total Patients Enrolled
Hirofumi Tanaka, PhDPrincipal InvestigatorThe University of Texas at Austin
3 Previous Clinical Trials
109 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are extremely overweight to the point of having serious health problems.You have high blood pressure.You are a smoker.You are taking medication that may impact your heart or blood vessels.You are currently doing weightlifting or other resistance training exercises.You have a heart condition that is already diagnosed and being treated.
Research Study Groups:
This trial has the following groups:- Group 1: Wide-rigid cuff
- Group 2: Narrow-elastic band
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger